Emcure Pharmaceuticals Ltd. - Research Center
544210 EMCURE Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | |
|---|---|
| Sales | 970.29 |
| Operating profit | 115.19 |
| Interest | 37.57 |
| Gross profit | 110.13 |
| EPS (Rs) | 2.23 |
Quarterly
results in details
| Jun' 24 | |
|---|---|
| Other income | 32.51 |
| Stock adjustment | -8.42 |
| Raw material | 266.07 |
| Power and fuel | - |
| Employee expenses | 195.09 |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 402.36 |
| Provisions made | - |
| Depreciation | 55.08 |
| Taxation | 14.60 |
| Net profit / loss | 40.45 |
| Extra ordinary item | - |
| Prior year adjustments | - |
| Equity capital | 181.15 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | 11.87 |
| GPM (%) | 10.98 |
| NPM (%) | 4.03 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis